Join the 'Hepatic Encephalopathy' group to help and get support from people like you.
Hepatic Encephalopathy News
Posted 29 Mar 2010 by Drugs.com
SILVER SPRING, Md., March 24 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved the use of Xifaxan for reduction in the risk of the recurrence of overt hepatic encephalopathy (HE) in patients with advanced liver disease. This is a new use for Xifaxan (rifaximin), a drug that has been approved for the treatment of traveler's diarrhea. Hepatic encephalopathy is a ...
Related Condition Support Groups
Related Drug Support Groups
lactulose, Xifaxan, neomycin, rifaximin, Duphalac, Kristalose, Enulose, Constilac, Heptalac, view more... Evalose, Cholac, Mycifradin, Cephulac, Chronulac, Neo-Tab, Generlac, Neo-Fradin, Constulose, Chronulac Syrup